Oscar Health Inc (NYSE: OSCR)’s stock price has gone rise by 0.14 in comparison to its previous close of 14.70, however, the company has experienced a -12.12% decrease in its stock price over the last five trading days. seekingalpha.com reported 2025-02-04 that Oscar Health, Inc. (NYSE:OSCR ) Q4 2024 Earnings Conference Call February 4, 2025 5:00 PM ET Company Participants Chris Potochar – Vice President of Treasury and Investor Relations Mark Bertolini – Chief Executive Officer Scott Blackley – Chief Financial Officer Conference Call Participants Stephen Baxter – Wells Fargo Josh Raskin – Nephron Research Michael Ha – Baird Jonathan Yong – UBS Jessica Tassan – Piper Sandler Adam Ron – Bank of America Operator Good evening. My name is Rob, and I will be your conference operator today.
Is It Worth Investing in Oscar Health Inc (NYSE: OSCR) Right Now?
Moreover, the 36-month beta value for OSCR is 1.74. Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 2 as “overweight,” 1 as “hold,” and 1 as “sell.”
The public float for OSCR is 173.80M and currently, short sellers hold a 11.36% of that float. On February 11, 2025, OSCR’s average trading volume was 4.19M shares.
OSCR’s Market Performance
OSCR stock saw a decrease of -12.12% in the past week, with a monthly decline of -3.73% and a quarterly a decrease of -5.34%. The volatility ratio for the week is 9.90%, and the volatility levels for the last 30 days are 6.79% for Oscar Health Inc (OSCR). The simple moving average for the last 20 days is -6.69% for OSCR’s stock, with a simple moving average of -15.56% for the last 200 days.
Analysts’ Opinion of OSCR
Many brokerage firms have already submitted their reports for OSCR stocks, with Jefferies repeating the rating for OSCR by listing it as a “Underperform.” The predicted price for OSCR in the upcoming period, according to Jefferies is $12 based on the research report published on December 10, 2024 of the previous year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see OSCR reach a price target of $13.50, previously predicting the price at $21. The rating they have provided for OSCR stocks is “Underperform” according to the report published on November 06th, 2024.
UBS gave a rating of “Neutral” to OSCR, setting the target price at $23 in the report published on October 07th of the previous year.
OSCR Trading at -3.34% from the 50-Day Moving Average
After a stumble in the market that brought OSCR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.13% of loss for the given period.
Volatility was left at 6.79%, however, over the last 30 days, the volatility rate increased by 9.90%, as shares surge +3.81% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.64% lower at present.
During the last 5 trading sessions, OSCR fell by -12.12%, which changed the moving average for the period of 200-days by -15.40% in comparison to the 20-day moving average, which settled at $15.77. In addition, Oscar Health Inc saw 9.52% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OSCR starting from STEVEN WOLIN, who proposed sale 36,034 shares at the price of $14.79 back on Feb 10 ’25. After this action, STEVEN WOLIN now owns shares of Oscar Health Inc, valued at $532,849 using the latest closing price.
Quane Alessandrea C., the EVP, Chief Insurance Officer of Oscar Health Inc, sale 16,793 shares at $16.16 during a trade that took place back on Dec 06 ’24, which means that Quane Alessandrea C. is holding 430,216 shares at $271,293 based on the most recent closing price.
Stock Fundamentals for OSCR
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 1.0 for the gross margin
The net margin for Oscar Health Inc stands at 0.0. The total capital return value is set at 0.04. Equity return is now at value 2.80, with 0.64 for asset returns.
Based on Oscar Health Inc (OSCR), the company’s capital structure generated 0.23 points at debt to capital in total, while cash flow to debt ratio is standing at 3.1. The debt to equity ratio resting at 0.3. The interest coverage ratio of the stock is 2.41.
Currently, EBITDA for the company is 88.62 million with net debt to EBITDA at -13.82. When we switch over and look at the enterprise to sales, we see a ratio of 0.21. The receivables turnover for the company is 29.05for trailing twelve months and the total asset turnover is 1.9. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.81.
Conclusion
To wrap up, the performance of Oscar Health Inc (OSCR) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
